The largest database of trusted experimental protocols

6 protocols using staphylococcus aureus enterotoxin b seb

1

Purified Pertussis Vaccine Antigens Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified genetically-detoxified Pertussis Toxin (PT; R9K, E129A; Limulus Amebocyte Lysate activity < 20 EU/mg) was purchased from LIST Biological laboratories Inc. (Campbell, CA, USA) and stored at 500 µg/mL at −20 °C. Purified Filamentous hemagglutinin (FHA) was kindly provided by Sanofi Pasteur (Marcy-l’Étoile, France) and stored at 700 µg/mL at 4 °C (Limulus Amebocyte Lysate activity < 66 EU/mg). A bacterial lysate of Bp strain B1917 [30 (link)] (Bp lysate/BPL) was kindly provided by Q Biologicals (Ghent, Belgium) and stored at 3.4 mg/mL at −80 °C. A peptide pool of 132 Bp immunogenic peptide sequences (referred to as peptide pool) from the five Bp vaccine antigens [15 (link)] was purchased from Pepscan (Lelystad, the Netherlands) and stored as a mix at 0.1 mM per peptide in PBS/10% DMSO at −20 °C. Staphylococcus aureus enterotoxin B (SEB) was purchased from Sigma (Saint Louis, MO, USA) and stored at 1 mg/mL at −20 °C. Purified anti-CD28 antibodies (stock concentration 1 mg/mL) and anti-CD49d antibodies (stock concentration 1 mg/mL) were purchased from eBiosciences (Landsmeer, The Netherlands). PT and Bp lysate were heat-inactivated for 10 min at 80 °C using a water bath to avoid any mitogenicity in the whole blood stimulations.
+ Open protocol
+ Expand
2

Allogeneic CD8+ T Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To study CD8+ T cell proliferation and functionality, 5000 DCs were stimulated as indicated and co‐cultured with 20 000 allogeneic naïve CD8+ T cells (CD8+, CD27+, CD45RO, and CD45RA+) in the presence of 1 pg/mL Staphylococcus aureus enterotoxin B (SEB; Sigma–Aldrich). To determine proliferation, CD8+ T cells were incubated with 0.5 μM CFSE (Invitrogen) and washed extensively prior to co‐culture. At day 3 or 4, cells were incubated overnight with the modified thymidine analogue EdU (Click‐iT kit; Invitrogen) and further processed according to the manufacturer's instructions. The percentage of divided cells (EdU+ or CFSE) was determined by flow cytometry (Canto II, BD Biosciences). To determine intracellular granzyme B expression, cells were harvested at day 4 or 5, washed with PBS, fixated with 4% formaldehyde (Sigma–Aldrich) for 15 min, washed again, permeabilized with 0.5% saponin (Calbiochem) in PBS containing 0.5% BSA (PAA) and 0.1% sodium azide (Merck), and stained with anti‐granzyme B‐PE (Sanquin Blood Supply) and analyzed by flow cytometry. For intracellular IFN‐γ or TNF staining, CD8+ T cells were restimulated at day 4 or 5 with 100 ng/mL PMA, 1 μg/mL ionomycin, and 10 μg/mL brefeldin A (all Sigma–Aldrich) for 6 h, washed, fixated, and permeabilized as described above, stained with anti‐IFN‐y‐ FITC and anti‐TNF‐APC (both BD Biosciences) and analyzed by flow cytometry.
+ Open protocol
+ Expand
3

Inferior Turbinate Tissue Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Preparation of human inferior turbinate tissue was performed, essentially as described [28 ]. In short, human nasal tissue was cut in RPMI1640 tissue culture medium (Sigma-Aldrich, Belgium), complemented with 2mM L-Glutamine (Invitrogen, Belgium), 50 IU/ml penicillin, 50mg/ml streptomycin (Invitrogen) and 0.1% BSA (Sigma-Aldrich). Subsequently these pieces were passed through a mesh to achieve comparable sized fragments (±0.9mm3). After 1h equilibration, the obtained tissue fragments were washed with fresh culture medium, weighed and resuspended into 48-well plates (BD Falcon; VWR International, Belgium) as 0.04g/ml in 0.5 ml RPMI1640 tissue culture medium, prepared as above. Tissue suspensions were pre-incubated with either solvent, methylprednisolone (MP) (ranging from 10-4M to 10-11M) or compound A (ranging from 10-4M to 10-11M) for 1 hour at 37°C and 5% CO2. Ensuing, tissue fragments were stimulated with 0.5 μg/ml (final concentration, fc) Staphylococcus aureus enterotoxin B (SEB, Sigma-Aldrich) for 24 hours. The SEB solvent PBS served as a negative control.
+ Open protocol
+ Expand
4

Antigen Preparation and Storage Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Soluble substance A (SS-A (60 kDa); MyBioscource Inc., San Diego, USA), soluble substance B (SS-B, Fitzgerald Industries Intl., Acton, USA), tetanus toxoid (TT, Merck-Millipore, Darmstadt, Germany), influenza hemagglutinin 3 neuroaminidase 2 (H3N2, Sino Biologicals, Beijing, China), and Staphylococcus aureus enterotoxin B (SEB, Sigma-Aldrich, Darmstadt, Germany). Ultrapure Lipopolysaccharide (LPS, E. coli 0111:B4, InvivoGen, San Diego, USA) was used at 100 ng/ml. All recombinant antigens were reconstituted and stored according to the manufacturer’s recommendations and aliquoted for single use to avoid freeze-thaw cycles.
+ Open protocol
+ Expand
5

HCV Peptide-Specific PBMC Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 28 and 98 peptides (15–19-mers with 11–12 amino acid (aa) overlaps) spanning the core and nonstructural protein 3 (NS3), respectively, of HCV subtype 1a (H77) and 1b (J4) were obtained through the NIH Biodefense and Emerging Infectious Research Resources Repository, NIAID, NIH (peptide arrays, HCV Core and NS3 proteins, NR-3737, NR-3747, NR-3752, NR-37452). Purified recombinant HCV NS3-helicase (aa: 1207–1488) proteins derived from subtype 1a and 1b sequences and expressed in the yeast Pichia pastoris were purchased from Mikrogen (Neuried, Germany).
PBMCs were stimulated with 4 μg/mL of overlapping HCV Core or NS3 pool peptides or 2 μg/mL of NS3 Helicase protein subtype 1a or 1b. PBMCs stimulated with 1 μg/mL of Staphylococcus aureus enterotoxin B (SEB; Sigma-Aldrich, Deisenhofer, Germany) or incubated with completed medium alone were used as positive and negative controls, respectively.
+ Open protocol
+ Expand
6

Evaluating Anti-CTLA-4 mAb Immune Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the immune activation efficacy of the anti-CTLA-4 mAb, bovine PBMCs were cultured with 10 μg/ml of anti-CTLA-4 mAb (4C2-D9) or mouse IgG (Sigma-Aldrich) in the presence of 0.1 μg/ml of Staphylococcus aureus enterotoxin B (SEB) (Sigma-Aldrich). The culture medium was harvested after 3 days, and interferon-γ (IFN-γ) concentrations in duplicate wells were measured using an ELISA (Mabtech, Nacka Strand, Sweden) according to the manufacturer’s protocol.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!